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Abstract – Background: The association between Dystonia and Parkinson’s disease (PD) has been well described 
especially for foot and hand dystonia. There is however few data on dystonic postures in patients with atypical 
parkinsonism.  Objective: To evaluate the frequency and pattern of dystonia in a group of patients with 
atypical parkinsonism (multiple system atrophy – MSA, progressive supranuclear palsy – PSP, and corticobasal 
degeneration – CBD) and to investigate whether dystonia could be the first presenting symptom at disease 
onset in those patients.  Method: A total of 38 medical charts were reviewed (n=23/MSA group; n=7/CBD 
group; n=8/PSP group) and data values were described as means/standard deviations. The variables evaluated 
were sex, age at onset, disease duration, first symptom, clinical features of dystonia and other neurological 
signs, response to levodopatherapy, Hoehn&Yahr scale >3 after three years of disease, and magnetic resonance 
imaging findings.  Results: The overall frequency of dystonia in our sample was 50% with 30.4% (n=7) in the 
MSA group, 62.5% (n=5) in the PSP group, and 100% (n=8) in the CBD group. In none of these patients, dystonia 
was the first complaint. Several types of dystonia were found: camptocormia, retrocollis, anterocollis, 
blepharoespasm, oromandibular, and foot/hand dystonia.  Conclusion: In our series, dystonia was a common 
feature in atypical parkinsonism (overall frequency of 50%) and it was part of the natural history although not 
the first symptom at disease onset. Neuroimaging abnormalities are not necessarily related to focal dystonia, 
and levodopa therapy did not influence the pattern of dystonia in our group of patients.
KeY worDS: dystonia, atypical parkinsonism, multiple system atrophy, progressive supranuclear palsy, 
corticobasal degeneration, Parkinson’s disease.
Características clínicas da distonia no parkinsonismo atípico
Resumo – Introdução: A associação de distonia e doença de Parkinson (DP) já foi bem estabelecida, 
principalmente para distonia focal em pé ou mão. entretanto, há poucos dados quanto a distonia em pacientes 
com parkinsonismo atípico.  Objetivo: Avaliar a freqüência e o padrão da distonia em um grupo de pacientes 
com parkisnonismo atípico (atrofia de múltiplos sistemas – AMS; paralisia supranuclear progressiva – PSP; 
degeneração corticobasal – DCB) e investigar se a distonia pode ser a manifestação inicial neste grupo.  Método: 
Um total de 38 prontuários médicos foi revisado (n=23/grupo AMS; n=8/grupo PSP; n=7/grupo PSP) e os 
dados foram apresentados em médias/desvios padrões. As variaveis avaliadas foram: sexo, idade de início, 
duração da doença, primeiro sintoma, características clínicas da distonia e outros sinais neurológicos, resposta 
ao tratamento com levodopa, escala de Hoehn & Yahr >3 em 3 anos de doença, e achados de ressonância 
magnética.  Resultados: A frequência total de distonia em nosso grupo foi 50%, sendo 30,4% (n=7) no grupo 
AMS, 62.5% (n=5) no grupo PSP e 100% (n=8) no grupo DCB. em nenhum dos pacientes, distonia foi o primeiro 
sintoma. Várias apresentações de distonia foram observadas: camptocormia, anterocólis, retrocólis, distonia 
oromandibular, em pé e mão.  Conclusão: em nossa série, distonia foi uma característica comum em pacientes 
com parkinsonismo atípico (freqüência de 50%) e fez parte da história natural em todos os grupos, embora não 
tenha sido o sintoma inicial em nenhum deles. Anormalidades no exame de neuroimagem não necessariamente 
estão relacionadas a distonia focal, e o tratamento com levodopa não influenciou o padrão da distonia em 
nosso grupo de pacientes.
PAlAVrAS-CHAVe: distonia, parkinsonismo atípico, atrofia de múltiplos sistemas, paralisia supranuclear 
progressiva, degeneração corticobasal, doença de Parkinson.
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Most patients who are referred to specialized move-
ment disorders clinics with akinetic-rigid forms of parkin-
sonism are generally diagnosed as having Parkinson’s dis-
ease (PD). The second most common group of parkinso-
nian patients is clinically categorized as having parkinson-
ism-plus disorders or atypical parkinsonism, such as mul-
tiple system atrophy (MSA) and progressive supranuclear 
palsy (PSP)1. Parkinsonism is considered atypical when the 
condition evolves rapidly, responds poorly or transient-
ly to levodopa therapy or has other clinical and neuro-
imaging-associated features2. A previous series of parkin-
sonian patients in Brazil found a lower frequency of MSA 
(1.8%) and PSP (2%) that could reflect a short follow-up 
period, since it is known that many patients initially di-
agnosed with PD later are found to have parkinsonism-
plus disorders3.
Postmortem studies reveal that a substantial propor-
tion of patients thought to have PD in life were, in fact, 
afflicted with other sporadic degenerative conditions 
such as MSA and PSP4. Dystonia, most often in the form 
of foot and hand posturing, occurs in untreated patients 
with clinical diagnosis of PD5. However, there is few data 
on the occurrence of the typical intermittent dystonic 
spasms that characterize idiopathic dystonia in MSA and 
PSP. Anterocollis certainly occurs in MSA, but may not be 
a true dystonia and more likely represents a special im-
balance of rigidity in neck muscles producing a sustained 
posturing. Frequently, the MSA patients exhibit orofacial 
dystonia associated with a characteristic high-pitched 
dysarthria In patients with PSP, late dystonic posturing 
of the limbs could represent contractures, and eye-lid el-
evator inhibition may have been confused with blepha-
roespasm5. on the other hand, asymmetrical limb dysto-
nia is a typical feature of patients with Corticobasal de-
generation (CBD). Although uncommon at presentation, 
60–70% of patients with CBD develop limb dystonia dur-
ing the clinical course6. other study found a high preva-
lence of joint and skeletal deformities in PD, MSA, and 
PSPincluding “striatal” hand, foot deformities, involuntary 
trunk flexion, anterocollis and scoliosis7.
our aim was to retrospectively investigate the fre-
quency and clinical features of dystonia in a group of pa-
tients with atypical parkinsonism (MSA, PSP and CBD), and 
also highlights the clinical presentation of each group at 
first neurological visit.
methoD
we reviewed the medical charts of twenty-three patients 
with probable MSA, eight patients with probable PSP and seven 
patients with probable CBD, according to the criteria of Gilman 
et al.8, litvan et al.9, and Gibb et al.10, respectively. 
we searched for the presence of dystonia and its clinical 
pattern in all patients. we also described demographic and clin-
ical features of all groups: sex, age at onset, disease duration be-
fore first neurological visit, first symptom, clinical signs at the 
neurological exam, response to levodopatherapy, Hoehn&Yahr 
scale >3 after three years of disease, and brain magnetic reso-
nance imaging (MrI) abnormalities.
Data were described as mean±standard deviation, and when-
ever possible percentages. 
This protocol was submitted to and approved by the local 
ethical committee.
results
on Table 1, we present the clinical features of the pa-
tients evaluated in the three groups: MSA, PSP, and CBD. 
on Tables 2, 3 and 4 we detailed the specific findings on 
dystonia in those groups aforementioned. 
The frequency of dystonia in our group of patients with 
atypical parkinsonism was: 30.4% (7 patients) in the MSA 
group, 62.5% (5 patients) in the PSP group, and 100% (8 pa-
tients) in the CBD group. overall, the frequency of dysto-
nia in our series was 50%. In none of these patients, dys-
tonia was their first complaint. we did not find among the 
patients with dystonia and brain MrI abnormalities a top-
ographic correlation between brain lesions and dystonia.
DisCussion
In this retrospective study of patients with atypical 
parkinsonism the overall frequency of dystonia found was 
high (50%) if we compare to the frequency of patients 
with PD. Another interesting finding was that dystonia was 
not the first symptom at onset disease in any patient with 
atypical parkinsonism. 
A common form of dystonia in patients with MSA is 
a severe, isolated anterocollis5,11. In our group of patients 
with MSA, only three subjects presented cervical dystonia 
(2 anterocollis and 1 retrocollis). Cervical dystonia, con-
tralateral arm, hand and foot dystonias, occurring alone 
or in various combinations, may be the manifestation of a 
structural lesion involving the head of the caudate nucle-
us12. In only one of our patients (patient 7 in MSA group) 
we were able to find an MrI abnormality that could jus-
tify dystonia. In fact, MrI is a useful diagnostic tool in the 
early course of MSA and it can be used to differentiate 
parkinsonian disorders13,14, but there is no clinical radio-
logical correlation to dystonia phenomenom. 
Since PSP was first characterized in 196415, dystonic 
manifestations have been reported only sporadically. 
retrocollis or “axial dystonia in extension” is the only 
such manifestation, which has been disclosed; however, 
the pathogenesis of this tonic, rigid extended posture 
is probably distinct from other forms of dystonia and is 
more correlated with interstitial nucleus of Cajal lesions 















Male/Female 13/10 3/5 3/4
onset age (year–old) 57.1±9.3 64.7±10.3 62.7±6.8
Disease duration before diagnosis (months) 30.4±12.6 36.3±26.2 52.3±26.1
Dystonia 7 (30.4%) 5/8 (62.5%) 7 (100%)
First symptom
























Asymmetric parkinsonism 2 (8.6%) 3 (37.5%) 7 (100%)
H&Y ≥3 in 3 years 20 (86.9%) 8 (100%) 6 (85.7%)
response to levodopa 4 (17.3%) 0 1 (14.3%)
Bradikinesia 23 (100%) 8 (100%) 6
rigidity 22 (95.6%) 8 (100%) 7 (100%)
Tremor 4 (17.3%) 2 (25%) 1 (14.3%)
Postural unsteadiness 22 (95.6%) 7 (87.5%) 2 (28.5%)
ocular movement abnormalities 8 (34.7%) 8 (100%) 3 (42.8%)
Postural hypotension 20 (86.9%) 1 (12.5%) 1 (14.3%)
Sphincters disorders 15 (65.2%) 1 (12.5%) 0
erectile dysfunction 11 (47.8%) 0 0
Cold blue hands 6 (26%) 0 1 (14.3%)
Pyramidal signs 12 (52.1%) 3 (37.5%) 4 (57.1%)
Cerebellar signs 5 (21.7%) 0 0
DSM-IV dementia 3 (13%) 0 1 (14.3%)
Dysphagia 14 (60.8%) 7 (85.5%) 3 (42.8%)
Dysartria 16 (69.5%) 8 (100%) 3 (42.8%)
Alien hand 0 0 4 (57.1%)
Table 2. Patients with MSA and dystonia.











1 F 54 36 Falls Anterocollis No Pons and cerebellum atrophy
2 F 64 12 Gait disorder Camptocormia No Normal
3 F 62 36 rigidity left foot No Normal
4 M 50 24 Bradikinesia left foot No Normal
5 F 76 36 Falls Anterocollis No Normal
6 M 64 36 Gait disorder retrocollis Yes Mesencephalum atrophy






in PSP tends to be fixed and does not alter with posture 
or activity as idiopathic dystonia does. Patients fail to 
show sensory tricks for improving the posturing, diurnal 
variation is absent (“morning benefit”), and painful neck 
spasms and hypertrophic muscles are not seen17. Two of 
our patients (patients 3 and 5) presented retrocollis and 
MrI abnormalities in brainstem. The MrI findings in pa-
tients with atypical parkinsonism reflect the involvement 
of many structures. The midbrain atrophy is particularly 
well demonstrated on midline sagittal images (“Humming-
bird sign”), showing reduced midbrain diameter, enlarged 
cerebral aqueduct and thinned quadrigeminal plate. Sig-
nal abnormalities are mild and consist of hyperintensity 
in the periaqueductal region on T2-weighted sequences 
(“Morning Glory sign”)18,19. The most widely reported dys-
tonic manifestation on PSP is blepharospasm20, but none 
of our patients presented such manifestation. Two of our 
patients (patients 2 and 4) presented limb dystonia. It is 
possible that limb dystonia in PSP is an indicator of con-
comitant cortical and basal ganglia neuropathological 
changes. It is becoming increasingly recognized that such 
cortical pathology does occur in PSP17. Interestingly, oro-
mandibular dystonia was observed in one of our patients 
and it was not related to levodopa therapy. The potential 
role of medication, especially levodopa, must be consid-
ered when dealing with dystonia in patients with PSP17. A 
Brazilian series of PSP patients observed that 13% had tran-
siently good response to levodopa, but it did not point 
out whether these patients also presented dystonia21. 
None of our patients with PSP responded to levodopa, 
including those who presented dystonia. 
Classically, typical features of CBD can be categorized 
into movement disorders (akinesia, rigidity, postural in-
stability, limb dystonia, cortical myoclonus and postur-
al/intention tremor) and cortical signs such as cortical 
sensory loss, apraxia and Alien hand phenomenon22. A 
rigid, dystonic posture arm with some fingers extended 
and others forcibly flexed into the palm causing skin mac-
eration characteristically develops early in the course of 
the illness in a substantial minority of patients5,22. Jerking 
of the affected limb due to action-induced and stimu-
lus sensitive focal reflex myoclonus commonly precedes 
or accompanies the development of such dystonic pos-
tures and, if rhythmic, may mimic tremor23. In our series, 
all patients with CBD presented limb dystonia, and five 
of them also had associated myoclonus. The brain MrI 
was abnormal in four patients, all presenting asymmetri-
cal brain atrophy (Table 4). In these patients the side with 
Table 3. Patients with PSP and dystonia.











1 F 74 72 Falls oromandibular No Mild Microangipathy
2 F 64 30 Falls right arm No “Hummingbird” sign
3 M 69 48 Falls retrocollis No Generalized cerebral atrophy
4 F 60 36 Falls left arm No “Hummingbird” sign
5 F 42 9 Gait disorder retrocollis No “Hummingbird” and 
“Morning Glory” signs
Table 4. Patients with CBD and dystonia.













1 F 65 60 Gait disorder left arm Yes No right frontal 
lobe atrophy
2 M 50 84 rigidity right arm Yes No Normal
3 F 60 24 rigidity left arm No No right parietal and 
tempotal lobes atrophy
4 F 62 72 Bradikinesia right arm Yes No Normal
5 F 71 72 Bradikinesia right arm and 
retrocollis
Yes No left frontal lobe 
atrophy
6 M 62 36 rigidity left arm and 
blepharoespasm
No No Global cortical 
atrophy (right > left)





more prominent atrophy was opposite to the side of limb 
dystonia. MrI findings of atrophy in the perirolandic gyri, 
atrophy of the basal ganglia, and T2 prolongation in the 
posterolateral putamen are useful evidence supporting 
the clinical diagnosis of corticobasal degeneration24. As 
expected, dystonia was not the chief complaint in any 
patient and did not respond to levodopa therapy.
Clinico-pathologic studies are needed to disclose the 
relationship between these dystonic manifestations and 
the pathological substrates of these atypical parkinson-
isms. we did not have a longer follow-up that could allow 
the observation of dystonia progression, and of those pa-
tients who initially did not have dystonic features but lat-
er developed these signs correlating to levodopa therapy.
In conclusion, in our series dystonia was a common 
feature in atypical parkinsonism (overall frequency 50%) 
and it was part of the natural history although not the 
first symptom at disease onset. Moreover, neuroimaging 
abnormalities are not necessarily related to focal dysto-
nia, and levodopa therapy did not influence the pattern of 
dystonia in our group of patients. Prospective studies of 
natural history and post-mortem brain pathological analy-
sis are necessary to disclosure a better comprehension of 
dystonia phenomenology in atypical parkinsonism.
referenCes
 1. Jankovic J, Rajput A, McDermott MP, Perl DP. The evolution of diagno-
sis in early Parkinson disease. Arch Neurol 2000;57:369-372.
 2. Brooks DJ. Diagnosis and management of atypical parkinsonian syn-
dromes. J Neurol Neurosurg Psychiatry 2002;72(Suppl 1):110-116.
 3. Cardoso F, Camargos ST, Silva GA Jr. Etiology of parkinsonism in a Bra-
zilian Movement Disorders Clinic. Arq Neuropsiquiatr 1998;56:171-175.
 4. Albanese A, Colosimo C, Bentivoglio AR, et al. Multiple system atro-
phy presenting as parkinsonism: clinical features and diagnostic crite-
ria. J Neurol Neurosurg Psychiatry 1995;59:144-151.
 5. Rivest J, Quinn N, Marsden CD. Dystonia in Parkinson’s disease, mul-
tiple system atrophy, and progressive supranuclear palsy. Neurology 
1990;40:1571-1578.
 6. Rinne JO, Lee MS, Thompson PD, et al. Corticobasal degeneration: a 
clinical study of 36 cases. Brain 1994;117:1183-1196.
 7. Ashour R, Jankovic J. Joint and skeletal deformities in Parkinson’s dis-
ease, multiple system atrophy, and progressive supranuclear palsy. Mov 
Disord 2006;21:1856-1863.
 8. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diag-
nosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
 9. Litvan I, Agyd Y, Calne D, et al. Clinical Research criteria for the diag-
nosis of progressive supranuclear palsy (Steele-Richardson-Olszewski 
syndrome): report of the NINDS-SPSP International Workshop. Neu-
rology 1996;47:1-9.
10. Gibb WRG, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 
1989;112:1171-1192.
11. Quinn N. Disproportionate anterocollis in multiple system atrophy. 
Lancet 1989;1:844.
12. Obeso JA, Gimenez-Roldan S. Clinicopathological correlation in symp-
tomatic dystonia. Adv Neurol 1988;50:113-122.
13. Seppi K, Schocke MF Wenning GK, Poewe W. How to diagnose 
MSA early: the role of magnetic resonance imaging. J Neural Transm 
2005;112:1613-1624.
14. Albuquerque AV, Freitas MRG, Cincinatus D, Harouche MBB. Multiple 
system atrophy: clinical-radiological correlation. Arq Neuropsiquiatr 
2007;65:512-515.
15. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. 
Arch Neurol 1964;10:333-359.
16.	 Fukushima-Kudo	J,	Fukushima	K,	Tashiro	K.	Rigidity	and	dorsiflexion	
of the neck in progressive supranuclear palsy and the interstitial nucle-
us of Cajal. J Neurol Neurosurg Psychiatry 1987;50:1197-203.
17. Barclay CL, Lang AE. Dystonia in progressive supranuclear palsy. J 
Neurol Neurosurg Psychiatry. 1997;62:352-356.
18. Barsottini OG, Ferraz HB, Maia AC Jr, Silva CJ, Rocha AJ. Differenti-
ation of Parkinson’s disease and progressive supranuclear palsy with 
magnetic	resonance	imaging:	the	first	Brazilian	experience.	Parkinson-
ism Relat Disord. 2007;13:389-393.
19. Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical par-
kinsonian syndromes with routine MRI. Neurology 2000;54:697-702.
20. Pfaffenbach DD, Layton DD, Kearns TP. Ocular manifestations man-
ifestations in progressive supranuclear palsy. Am J Ophthalmol 
1972;74:1179-1184.
21. Carrilho PEM, Barbosa ER. Progressive supranuclear palsy in a sam-
ple of Brazilian population: clinical features of 16 patients. Arq Neu-
ropsiquiatr 2002;60:917-922.
22. Riley DE, Lang AE, Lewis A, et al. Cortical-basal ganglionic degenera-
tion. Neurology 1990;40:1203-1212.
23. Thompson PD, Shibasaki H. Myoclonus in corticobasal degeneration 
and other neurodegenerations. Adv Neurol 2000;82:69-82.
24. Tokumaru AM, O’uchi T, Kuru Y, Maki T, Murayama S, Horichi Y. Cor-
ticobasal degeneration:MR with histopathologic comparison. AJNR Am 
J Neuroradiol. 1996;17:1849-1852. 
